Patents

US 8216571 B2: Fully human anti-VEGF antibodies and methods of using

Granted
2012-07-10
Filed
2008-10-20 application 12739383
Type
Utility · 21 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Disclosed herein are fully human antibodies and antigen-binding fragments thereof that specifically bind human VEGF and inhibit VEGF binding to VEGF-R1 and VEGF-R2, and therefore inhibit VEGF signaling. The antibodies and antigen-binding fragments disclosed herein may be used, for example, to treat angiogenesis and conditions associated with angiogenesis both in vivo and in vitro.

Source: PVGPATDIS, file of 2026-04-10 (ipg120710.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
SCHERING CORPORATION 216 patentsUS company or organizationKenilworth, NJSCHERING CORPORATION State business registration EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Sumant RamachandraNorthbrook, IL8PVGPATDIS, file of 2026-04-10
Walter Robert BishopPequannock, NJ1PVGPATDIS, file of 2026-04-10
Linda MasatWalnut Creek, CA20PVGPATDIS, file of 2026-04-10
Chao Bai HuangSan Leandro, CA11PVGPATDIS, file of 2026-04-10
Toshihiko TakeuchiOakland, CA18PVGPATDIS, file of 2026-04-10
Seema KantakPacifica, CA3PVGPATDIS, file of 2026-04-10
Chin-Yi HuangFremont, CA22PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K16/22PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P3/10PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K2039/505PVGPATDIS, file of 2026-04-10
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digestsY10S435/81PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-12-23Release of security interest
Release of security interest
SILICON VALLEY BANK signed 2025-12-19XOMA TECHNOLOGY LTD. EMERYVILLE, CA73790/484PASDL, file of 2026-10-15
2018-05-09Security interest Security interest
Security interest
XOMA TECHNOLOGY LTD. signed 2018-05-07SILICON VALLEY BANK SAN FRANCSICO, CA46115/459PASDL, file of 2026-10-15
2012-08-30Name change
Change of name
SCHERING CORPORATION signed 2012-05-02MERCK SHARP & DOHME CORP. RAHWAY, NJ28884/151PASDL, file of 2026-10-15
2011-06-06Assignment
Assignment of assignor's interest
RAMACHANDRA, SUMANT signed 2010-09-11
BISHOP, WALTER ROBERT signed 2010-09-21
SCHERING CORPORATION KENILWORTH, NJ26391/726ECORSEXC, file of 2026-09-25
2011-01-10Assignment
Assignment of assignor's interest
RAMACHANDRA, SUMANT signed 2010-09-11
BISHOP, WALTER ROBERT signed 2010-09-21
SCHERING CORPORATION KENILWORTH, NJ25608/18ECORSEXC, file of 2026-09-25
2010-12-20Assignment
Assignment of assignor's interest
MASAT, LINDA signed 2010-08-24
HUANG, CHAO BAI signed 2010-08-26
HUANG, CHIN-YI signed 2010-08-26
TAKEUCHI, TOSHIHIKO signed 2010-08-26
KANTAK, SEEMA signed 2010-09-02
XOMA TECHNOLOGY LTD. BERKELEY, CA25530/902ECORSEXC, file of 2026-09-25
2010-12-20Assignment
Assignment of assignor's interest
RAMACHANDRA, SUMANT signed 2010-09-11
BISHOP, WALTER ROBERT signed 2010-09-21
SCHERING CORPORATION KENILWORTH, NJ25530/838ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.